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1. Introduction 
In a healthy body, reactive oxygen species (ROS) and antioxidants remain in balance. 
Oxidative stress occurs when the generation of reactive oxygen species and other radical 
species exceeds the scavenging capacity by antioxidants of antioxidative agents in organism, 
due to excessive production of reactive oxidagen species and/or inadequate intake or 
increased utilization of antioxidants. Most ROS are formed at operation of electrone 
transport chains in mitochondria, endoplasmatic reticulum, plasmatic and nuclear 
membranes. Minor ROS amounts are generated by some enzymes through autooxidation of 
different molecules. Reactive oxygen specieses can also be formed by exogenous exposures 
such as alcohol, tobacco smoke, and environmental pollutants. Elimination of reactive 
oxygen species is catalysed by certain enzymes such as superoxide dismutses (SOD), 
catalases and peroxidases. Antioxidants (including vitamins C and E) and antioxidant 
cofactors (such as selenium, zinc, and copper) are capable to dispose, scavenge, or suppress 
ROS formation. „Oxidative stress” rises when due to some reasons the steady-state ROS 
concentration is increased, leading to oxidative modification of cellular constituents, 
resulting disturbance of cellular metabolism and regulatory pathways (Lushchak. 2011). 
Cellular ROS and their control by antioxidants are involved in the physiology of the female 
reproductive system. Physiological ROS levels play an important regulatory role through 
various signalling and transduction pathways in folliculogenesis, oocyte maturation, corpus 
luteum, uterine function, embryogenesis, embryonic implantation and fetoplacental 
development. Imbalances between antioxidants and ROS production are considered to be 
responsible for the initiation or development of pathological processes affecting female 
reproductive processes.  
The establishment of pregnancy requires a receptive uterus able to respond to a variety of 
biochemical and molecular signals produced by the developing conceptus, as well as 
specific interactions between the uterine endometrium and the extra-embryonic membranes. 
Therefore, placental development and function are prerequisites for an adequate supply of 
nutrients and oxygen to the fetus and successful establishment of pregnancy. Oxidative 
stress has been proposed as the causative agent of female sterility, recurrent pregnancy loss 
and several pregnancy-related disorders as preeclampsia, intra-uterine growth restriction 
(IUGR) and gestational diabetes.  
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2. Effect of oxidative stress on female reproductive system 
The female reproductive system is a complex multiorgan system which require an optimal 
biological environment. Aerobic metabolism utilizing oxygen is essential for reproductive 
homeostazis. Aerobic metabolism is associated with the generation of prooxidant molecules 
called ROS including hydroxyl radical, superoxide anion, hydrogen peroxide, and nitric 
oxide. The balance between the prooxidants and antioxidants maintain the cellular 
homeostasis, whenever there is an imbalance in this equilibrum leading to enhanced steady-
state level a state of oxidative stress is initiated. Free radicals are key signal molecules 
modulating reproductive functions by the influence of the endometrial and fallopian tube 
function, maturation of oocytes, sperm, implantation of the preembryo and early embryo 
development (Figure 1.) 
 
Fig. 1. Oxidative stress in female reproduction 
2.1 Ovarian function 
Aerobic metabolism utilizing oxygen is essential for developement of the gametes, also free 
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various biomarkers of oxidative stress has been investigated in normal cycling human 
ovaries (Maruyama et al. 1997, Matsui et al., 1996), justifiing the regulatory role of ROS and 
antioxidants in oocyte maturation, folliculogenesis, ovarian steroidogenesis and luteolysis 
(Shiotani et al., 1991; Behrman et al., 2001; Sugino et al., 2004). Studies demonstrate 
intensified lipid peroxidation in the preovulatory Graafian follicle (Paszkovski et al., 1995). 
The significance of reactive oxygen specieses and antioxidant enzymes as copper zinc 
superoxide dismutase (Cu, Zn-SOD), manganese superoxide dismutase (Mn-SOD), and 
glutathione peroxidase, in oocyte maturation was provided by Riley et al. (1991) using 
immmunohistochemical localization and mRNA expression (Tamate et al., 1995). The 
antioxidant enzymes neutralize reactive oxygen specieses and protect the oocyte. In corpora 
lutea collected from pregnant and nonpregnant patients, it was observed that during normal 
situations Cu–Zn SOD expression rise from early luteal to midluteal phase and decrease 
during regression of the corpus luteum. Studies investigating the correlation between 
adrenal-4 binding protein (Ad4BP) and superoxide dismutase expression also suggest an 
association between oxidative stress and ovarian steroidogeneis (Matsui et al.,1996). 
Antibody to adrenal 4-binding protein (Ad4BP) was utilized to localize Ad4BP in the nuclei 
of theca and granulosa cells. Ad4BP is a steroidogenic transcription factor that induces 
transcription of the steroidogenic P450 enzyme. Both human granulosa and luteal cells 
respond to hydrogen peroxide with an extirpation of gonadotropin action and inhibition of 
progesterone secretion (Sabuncu et al., 2001). The production of both progesterone and 
estradiol hormones is reduced when hydrogen peroxide is added to a culture of human 
chorionic gonadotropin-stimulated luteal cells (Agrawal et al., 2006).  
Levels of three oxidative stress biomarkers, conjugated dienes, lipid hydroperoxide and 
thiobarabituric acid reactive substances were found significantly lower in the follicular fluid 
compared with serum levels (Jozwik et al., 1999). The preovulatory follicle has a potent 
antioxidant defense, which is depleted by the intense peroxidation (Jozwik et al., 1999). Also 
the antioxidant enzymes glutathione peroxidase and Mn-SOD are considered to be markers 
for cytoplasmic maturation in metaphase II oocytes (El Mouattasim et al., 1999). 
2.2 Changes in endometrium 
Cyclical changes in the endometrium are accompanied by changes in the expression of 
antioxidants. Enzymes, such as thioredoxin, have a higher expression in the early secretory 
phase (Murayama et al, 1997). There is also a cyclical variation in the expression of 
superoxide dismutase  in the endometrium. Superoxide dismutase activity decreased in the 
late secretory phase while ROS levels increased and ROS triggered the release of 
prostaglandin F2 ǂ (Sugino et al., 1996). Estrogen or progesterone withdrawal led to 
increased expression of cyclooxygenase-2 (COX-2). Stimulation of the cyclooxygenase 
enzyme is brought about by ROS via activation of the transcription factor NF-κB, suggesting 
a mechanism for menstruation (Sugino et al., 2004).  
Nitrogen monoxide (.NO) has also important role in decidualisation and preparation of the 
endometrium for implantation by regulatation of the endometrial, myometrial and 
microvascular functions. Expression of endothelial and inducible NO synthase (NOS) have 
been demonstrated in the human endometrium (Tseng et al., 1996), and the endometrial 
vessels (Taguchi et al,. 2000). Highest levels of transcripts of endothelial NOS mRNA have 
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been reported in the late secretory phase of the endometrium (Tseng et al., 1996). These 
changes have been hypothesized to be important in the genesis of menstruation and 
endometrial shedding. 
2.3 Fallopian tube function 
Several studies demonstrated the presence of cytokines, prostaglandins, metabolites of lipid 
peroxidation and ROS in fluid samples of fallopain tube (Tamate et al., 1985). The eqilibrum 
of these components serves as an optimal milieu for fertilization and the transport of the 
preembryo. An endogenous nitrogen monoxide system exists in the fallopian tubes. Nitric 
oxide has a relaxing effect on smooth muscle and it has similar effects on tubular 
contractility. Deficiency of NO may lead to tubal motility dysfunction, resulting in retention 
of the ovum, delayed sperm transport and infertility. Increased NO levels in the fallopian 
tubes are cytotoxic to the invading microbes and also may be toxic to spermatozoa (Rosselli 
et al., 1995), leading to infetility. 
2.4 Embryo implantation and placenta 
The human embryo undergoes interstitial implantation by invading the maternal decidua at 
the blastocyst stage (Riley& Behrman, 1991). Although placental villi are bathed in maternal 
blood in the hemochorial placenta (Tamate et al., 1995), prior to 10 weeks of gestation 
maternal blood flow to the placenta is blocked by extravillous trophoblasts. Placentation is 
initiated when the blastocyst makes contact with the epithelial lining of the uterus shortly 
after implantation. Placental villi which consist of a mesenchymal core surrounded by a 
monolayer of mononuclear villous cytotrophoblast stem cells which either fuse to form the 
overlying multinucleated syncytiotrophoblast or, in anchoring villi, differentiate into 
extravillous trophoblasts which grow out from the villous and spread laterally around the 
placenta (Irving et al., 1995). 
Invasive extravillous trophoblasts play an important role in adapting the decidua to sustain 
pregnancy. Extravillous trophoblasts invade the walls of the uterine spiral arteries and 
adapt these vessels into large bore conduits capable of delivering the increased blood supply 
required in the second and third trimesters (Robertson et al., 1967; Zhou et al., 1997). As the 
extravillous trophoblasts invade the spiral arteries early in pregnancy they form plugs 
which occlude the spiral arteries and prevent maternal blood from entering the intervillous 
space, creating a physiologic hypoxic environment (Hustin &nd Schaaps,1987;  Jaffe et al., 
1997; Burton et al., 1999). 
Early placental and embryonic development occurs in a state of low oxygen in histiotroph 
manner (Evans et al., 2004). The early gestation placenta is poorly protected against 
oxidative damage, as the antioxidant enzymes Cu,Zn-SOD and Mn-SOD are not expressed 
by the syncytiotrophoblast until approximately 8–9 weeks of gestation (Watson et al., 1997). 
Premature perfusion of this space during this first 10 weeks of development increases the 
risk of pregnancy loss (Jauniaux et al., 2000). The low oxygen environment during early 
placental development is essential for normal placental angiogenesis, and this angiogenesis 
is promoted by hypoxia-induced transcriptional and post-transcriptional regulation of 
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The partial oxygen tension in the intervillous space declines from the second to the third 
trimester, reaching about 40 mm Hg in the third trimester (Soothill et al., 1986). The exact 
mechanism by which trophoblasts sense oxygen tension is currently unclear; however, 
several potential pathways have been identified. Many of these pathways utilize the ROS 
formation, but it is currently unclear whether hypoxia results an increase or decrease in their 
cellular levels (DeMarco & Caniggia, 2002). In hypoxic conditions, trophoblast oxygen 
sensing mechanisms utilize several different pathways to control gene expression. These 
pathways often utilize redox-sensitive transcription factors, of which the hypoxia inducible 
factor (HIF) family are the best characterized. HIF-1 is a transcription factor and master 
regulator of the cellular response to low oxygen levels (Majmundar et al., 2010), showing 
prominent expression in first trimester villi (Wang&Semenza, 1993). HIF-1 regulates the 
expression of genes such as p53, p21, and Bcl-2 required for cells to adapt to a low oxygen 
environment and apoptosis. HIF-1 is able to be stabilized under normoxic conditions by a 
variety of growth factors and cytokines including epidermal growth factor (EGF), insulin, 
heregulin, insulin-like growth factors 1 and 2, transforming growth factor, and interleukin-1 
(Zelzer et al., 1998; Feldser et al., 1999; Hellwig-Burgel et al., 1999; Laughner et al., 2001; 
Fukuda et al., 2002; Stiehl et al., 2002).  
Several other transcription factors involved in trophoblast differentiation are responsive to 
hypoxia. The transcription factors Id1 stream stimulatory factor-1 and -2 (USF1 and USF2) 
mediate the effects of Mash2 are all up-regulated in 2% oxygen in comparison to 20% 
oxygen (Jiang et al., 2000; Jiang & Mendelson, 2003). The up-regulation of Mash2, USF1 and 
USF2 may inhibit cytotrophoblast fusion into syncytiotrophoblast (Jiang et al., 2000; Jiang& 
Mendelson, 2003). The elevation of intracellular Ca2+ is believed to activate an HIF-1-
independent signalling pathway that involves the transcription factor activator protein-1 
(AP-1), with cooperation between the HIF-1 and AP-1 pathways allowing fine regulation of 
gene expression under hypoxia (Laderoute et al., 2002; Salnikow et al., 2002). AP-1 is a 
dimeric transcription factor composed from the products of the Jun and Fos proto-
oncogenes (c-Jun, JunB, JunD, c-Fos, FosB, Fra-1 and Fra-2) (Dakour et al., 1999). AP-1 
transcription factors are believed to play an important role in trophoblast differentiation. In 
the villus, AP-1 transcription factor expression is limited; however, extravillous trophoblasts 
express c-Jun, JunB, c-Fos, FosB and Fra-2 both in the first trimester and later in gestation 
(Bamberger et al., 2004.) 
The other protective system is formed by antioxidant enzymes, playing a key role in the 
response of trophoblast to the burst of perfusion by maternal blood. With the increase of 
oxygen saturation and oxidative stress the activity in intervillous space the placenta 
employs a number of physiologic adaptations (Burton, 2009). Levels and activity of 
antioxidant enzymes: catalase, glutathione peroxidase, manganese and cooper, zinc 
superoxide dismutase are increased within placental tissues. This response is evolved as a 
defense mechanism to reduce harm to placental tissues exposed to this burst of oxidative 
stress (Jauniaux et al., 2000). 
We can summarize that the trophoblast differentiation is essential for the success of human 
pregnancy, and despite some conflicting experimental evidence, hypoxia appears to play a 
vital role in regulating trophoblast differentiation in the first trimester. The regulation of 
trophoblast differentiation by hypoxia is a result of complex interactions between factors 
associated with oxidative stress, oxygen sensing mechanisms and the release of 
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inflammatory cytokines. Therefore, aberrations in any one of these factors, along with the 
temporal and spatial regulation of blood flow in the intervillous space has the potential to 
result in altered gene expression and trophoblast phenotype leading to fail of implantation. 
3. The role of oxidative stress in embryo and fetal malformation 
Basic principles of teratogenesis state that a teratogen must cause a specific malformation 
through a specific mechanism during a period in which the conceptus is susceptible to said 
mechanism (Karnofsky, 1965). Different mechanisms are responsible for malformations that 
are in agreement with these basic scientific principles. 
A mechanism that has not been well described in teratology is oxidant induced or redox 
misregulation of developmental signals en route to dysmorphogenesis. The paucity of 
teratogenic study of redox misregulation is partially due to oxidative stress (Sies, 1985). 
Oxidizing and reducing equivalent imbalance in turn, leads to macromolecule damage, 
namely protein modification, lipid peroxidation, and DNA oxidation, and can lead to cell 
death. Unspecific oxidation of cellular components does not apply to basic principles of 
teratology or adequately explain the manifestation of teratogenic effects. If oxidative stress is 
the random, unspecific oxidation of cellular molecules, it does not adequately exemplify 
why or how specific teratogens that induce oxidative stress could cause a specific 
malformation. While untimely cell death during differentiation can have serious 
repercussions on the developing embryo, generalized cellular oxidation and subsequent 
apoptosis do not sufficiently describe specificity of malformations seen with most 
teratogens. To qualify as a plausible teratogenic mechanism, oxidative stress must be a 
controlled, specific event that alters cell function and/ or signal transduction pathways that 
would in turn cause specific dysmorphogenesis. 
During particular periods in development, the embryo is more or less susceptible to 
oxidative stress. In early development, one-cell embryo relies on the Krebs cycle, whereas 
the blastocyst relies on glycolysis and anaerobic pathways as does the embryo during early 
organogenesis. Once the circulatory system is established, there is a higher reliance on 
oxidative and aerobic metabolism and more ROS are produced by mitochondria. 
Conversely, more antioxidants are available at this period to counteract and detoxify these 
reactive oxygen specieses (Hansen, 2006). Over the course of development, the delicate 
balance between oxidants and antioxidants can be disrupted by exogenous agents that 
simulate ROS production leading to oxidative stress.  
Thalidomide is associated with multiple birth defects, including phocomelia (Lecutier, 1962; 
Taussig, 1962). The most sensitive organ to thalidomide toxicity is the limb. Although the 
mechanism of teratogenesis  and determinants of risk remain unclear, related teratogenic 
xenobiotics are bioactivated by embryonic prostaglandin H synthase (PHS) producing 
reactive oxygen species, which cause oxidative damage to DNA and other cellular 
macromolecules.  Similarly, thalidomide is bioactivated by horseradish peroxidase, and 
oxidizes DNA  and glutathione, indicating free radical-mediated oxidative stress. 
Furthermore, thalidomide teratogenicity is reduced by the PHS inhibitor acetylsalicylic acid, 
indicating PHS-catalyzed bioactivation. This appears to be regulated through redox shift 
resulting from depletion of GSH and increased GSSG in the nucleus, and this may imply 
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that various transcription factors are affected by thalidomide through redox regulation 
(Hansen et al., 2001, 2002). 
Exposure to the anticonvulsant valproic acid during the first trimester of pregnancy is 
associated with an increased risk of congenital malformations including heart defects, 
craniofacial abnormalities, skeletal and limb defects, and most frequently, neural tube 
defects (NTDs). The mechanisms by which valproic acid  induces teratogenic effects are not 
fully understood, although previous studies support a role for oxidative stress. Valproic 
acid can alter cell signaling through gene expression changes mediated through histone 
deacetylase inhibition (Phiel et al., 2001), and is a direct inhibitor of class I and II histone 
deacetylases. Several laboratories have shown that embryonic histone acetylation levels are 
increased following exposure to valproic acid (Menegola et al., 2005; Tung and Winn, 2010). 
Furthermore, studies have supported a role for histone deacetylase inhibition as a 
mechanism of teratogenesis as analogs of valproic acid that lack histone deacetylase 
inhibitory activity are less teratogenic (Gurvich et al., 2005). Gene microarray studies have 
also demonstrated that valproic acid targets genes regulated by histone deacetylase, 
including Mt1 and Mt2, both of which are ROS-sensitive (Jergil et al., 2009). In addition, 
histone deacetylase inhibitors have also been shown to increase ROS production and induce 
apoptosis in several cancer cell lines (Carew et al., 2008). Therefore, alterations in gene 
expression and/or increases in ROS formation mediated by histone deacetylase inhibition 
during development may induce teratogenesis. 
The widely used anticonvulsant, phenytoin, can double the incidence of structural and 
functional birth defects when used in pregnancy (Kaneko et al., 1991). It can induce 
vascular disruption, which leads to hypoxia and hypoperfusion (Danielsson et al.,1995). 
In addition, phenytoin results in oxidative DNA damage and dysmorphogenesis, which 
can be eliminated by antioxidants (Winn and Wells, 1995). Phenytoin also selectively 
increased NF-kB activity in targeted tissues. Blocking of these signaling events with p65 
antisense oligonucleotides eliminated the associated embryopathies (Kennedy et al., 
2004). Further evidence that oxidative stress is important in phenytoin mediated toxicity 
is exemplified by the fact that treatment with polyethylene-modified  superoxide 
dismutase  enhances embryo toxicity whereas antioxidant levels were modulated with 
phenytoin (Winn and Wells, 1999). 
Chronic ethanol consumption can lead to the generation of ROS and, as a consequence, 
teratogenicity. Prolonged ethanol exposure lead to increased production of lipid peroxides and 
decreased expression of antioxidant enzymes. Ascorbic acid can prevent against ethanol 
toxicity through inhibition of ROS formation and NF-kB activation (Peng et al.,2005). Zebrafish 
embryos exposed to ethanol with lipoic acid and/or only partially attenuated ethanol embryo 
toxicity, suggesting that other mechanisms are also involved (Reimers et al., 2006). 
4. Oxidative stress in pathological pregnancies 
4.1 Preeclampsia 
Preeclampsia is a complex multisystem disorder that occurs during the pregnancy. The 
disease affects 5-8% of all pregnancies and is one of the leading couses of maternal and fetal 
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morbidity and mortality. It is characterized with hypertension and proteinuria. The systolic 
blood pressure ≥140 mmHg, diastolic blood pressure ≥ 90 mmHg and the proteinuria at 
least 300 mg in 24 h urine collection. Women with mild proteinuria generally have no 
symptoms. However, women with severe preeclampsia (blood presure ≥160/110 mmHg, 
proteinuria >2-5g/24h) may have simptoms such as renal insufficiency, liver disease, 
haematological and neurological disturbances. Preeclampsia is charactized by vasospasm, 
reduced placental perfusion and abnormal placentation. The main couse of fetal 
compromise is the disturbance in uteroplacental perfusion. The only cure is the delivery of 
the baby. With antihypertensive treatment may prolong the pregnancy, increasing the 
chances of the baby to survive. If the blood presure cannot be controlled, or the laboratory 
parameters entry in a critical value the baby must be delivered. Preeclampsia has been 
proposed as a two-stage disorder. In first stage the placenta produces cytotoxic factors, in 
the second stage the maternal response to the placental factors occurs. There are several 
theories regarding to the main couse of disorder: abnormal placentation, immunological 
background, abnormal inflamatory response, etc. Assuming preeclampsia literature we can 
conclude that all the theories are part of disorders etiology. 
4.1.1 Oxidative agents 
Some reserches suggest that the placental oxidative stress may be involved in the 
ethiopathogenesis of preeclampisa. As there was mentioned above, the oxidatives stress is 
described as an imbalance in the production of reactive oxygen specieses and the ability of 
atioxidant defense to scavenge them. Pregnancy is a state of oxidative stress arrising from 
the increased metabolic activity in the placenta and reduced scavenging power of 
antioxidants (Wisdom et al. 1991). During the gestation the oxygenation of the 
uteroplacental unit is changing. The placenta and fetus exist in a hypoxic enviromet during 
early pregnancy as the uterine oxygen tension is extremly low till 8-10. weeks of gestation 
(pO2<20  mmHg, 5%O2), prior to estabilishment of the blood flow into intervillous space. 
The onset of blood flow is processig from the periphery to the center of placental disc, with 
villous regression in the placental periphery envolving into the chorion leave (Jauniaux et 
al., 2003). The developing chorioallantoic villous trees are exposed to a marked increase of 
pO2 in a range of 40-80 mm Hg (Sjostedt et al., 1960; Shaaps et al., 2005; Rooth et al., 1961). 
This reoxygenation of the uteroplacental unit results an oxidative burst, controlled by 
antioxidant mechanisms.  
Proposed effect of oxidative stress on placental fatty acid metabolism.  
As a consequence of abnormal trophoblast invasion, and maternofetal barrier preeclampsia 
is characterized by induced oxidative stress and decreased antioxidants (Patil et al., 2009). In 
preeclamptic women, maternal circulating levels, placental tissue levels and production rate 
of lipid peroxides are increased and several antioxidants are markedly decreased (Serdar et 
al., 2003; Orhan et al., 2003). Normal pregnancy is associated with physiological 
hyperlipidemia (Belo et al., 2004). Physiological alterations are manifested by increased 
levels of triglycerides and cholesterol in pregnancy, which decreases rapidly after delivery. 
Preeclampsia is characterized by further elevation of serum triglycerides and serum free 
fatty acids (Hubel et al., 1996). (Figure 2.) Increased lipid peroxidation has been reported in 
preeclampsia, IUGR (Liu et al., 2005; Gupta et al., 2004, Bretelle et al., 2004). 
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Fig. 2. Supposed oxidative stress pathway in preeclampsia  
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is an important enzyme 
that generates superoxide anion radical localized in the placenta syncytial microvillous 
membrane (Matsubara & Sato, 2001; Raijmakers et al., 2004). NADPH oxidase may play a 
role in placental lipid peroxidation by generating increased amounts of the superoxide 
anion radical. Poor antioxidant reserves can also tilt the balance in favor of prooxidation. 
Lipid peroxidation results in formation of primary lipid peroxidation products such as lipid 
hydroperoxides and secondary products such as malondialdehyde (MDA) and lipid 
peroxides. Lipid hydroperoxides are formed and bind to lipoproteins. They are then carried 
to distant sites where the hydroperoxides can cause ongoing lipid peroxidation and result in 
systemic oxidative stress. Increased placental production of lipid peroxides and 
thromboxane was demonstrated from both the trophoblast and the villous core components 
of placentas in patients with preeclampsia (Walsh & Wang, 1995). 
Studies of women undergoing cesarean section showed significantly higher contents of lipid 
hydroperoxides, phospholipids, cholesterol and free 8-iso-prostaglandin F2ǂ (8-iso-PGF2ǂ), 
but not the total (free plus esterified) 8-iso-PGF2ǂ in decidual tissues from women with 
preeclampsia as compared with tissues from normal pregnancies (Staff et al., 1999). 
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Moreover, tissue levels of free and total 8-iso-PGF2ǂ are significantly higher in preeclamptic 
placenta than in normal placenta (Walsh et al., 2000). Isoprostanes like 8-iso-PGF2ǂ are 
produced specifically by free radical-catalyzed peroxidation of arachidonic acid (Morrow et 
al., 1990). Free 8-iso-PGF2ǂ has activities of relevance to preeclampsia, being a potent 
vasoconstrictor in kidney (Morrow et al., 1990) and placenta (Kwek et al., 1990), platelet 
activator (Minzu et al., 2002), and inducer of the release of endothelin from endothelial cells 
(Yura et al. 1999). 
An increase in diastolic pressure correlates significantly with an increase in lipid peroxide 
levels, indicating that the severity of hypertension is correlated with the extent of lipid 
peroxidation (Aydin et al., 2004; Jain & Wise, 1995; Gupta et al., 2006). Women with 
preeclampsia have significantly higher mean plasma levels of malonaldehyde and 
significantly lower superoxide dismutase levels compared with normotensive pregnant 
women, (Aydin et al., 2004). The decrease in nitric oxide (NO) and superoxide dismutase 
(SOD) levels followed by a concomitant increase in levels of malonaledehyde, fibronectin, 
endothelin-1 (ET-1), and soluble-E selectin (sE-selectin) correlate with an increase in 
diastolic blood pressure (Aydin et al., 2004). In further studies, malonaldehyde levels in 
maternal erythrocytes were significantly elevated in women with developed preeclampsia. 
The risk of developing preeclampsia was 24-fold higher when malonaldehyde levels were 
above the cutoff value of 36 nmol/g (Basbug et al., 2003). 
The cord plasma malonaldehyde and vitamin E levels were higher in patients with 
eclampsia than in patients with preeclampsia and in normotensive pregnant patients 
(Bowen et al. 2001).  
Hyperhomocystinemia and altered eicosanoid synthesis has also been implicated in the 
pathophysiology of preeclampsia. Eicosanoids have vasoactive properties and enhance lipid 
peroxidation and decrease prostacyclin synthesis. The generation of the eicosanoid, 15-
hydroxyeicosateranoic acid by the placenta was higher in women with preeclampsia than in 
normotensive control subjects. In preeclampsia, there is increased synthesis of thromboxane 
and reduced synthesis of prostacyclin. Lipid peroxides may also stimulate the 
cyclooxygenase enzyme to produce more thromboxane, resulting in a hypercoagulable state 
(Walsh, 2004). 
4.1.2 Antioxidant agents 
Antioxidants can be enzymatic or nonenzymatic. The enzymatic antioxidants are superoxide 
dismutase, thioredoxin, thioredoxin reductase, and glutathione peroxidase. The 
nonenzymatic antioxidants can be lipid-soluble such as vitamin E or water-soluble such as 
vitamin C. Serum levels of vitamin E and beta carotene (Serdar et al., 2003; Akyol et al., 
2000), serum coenzyme Q10 and tocopherol levels (Palan et al., 2004), ascorbic acid were 
significantly reduced in pregnancies complicated by mild or severe preeclampsia, and the 
total antioxidant capacity was significantly reduced in pregnant women with mild and 
severe preeclampsia (Sagol et al., 1999). The balance between lipid peroxides and 
antioxidant vitamin E is tipped in favor of lipid peroxides in patients with mild and severe 
preeclampsia. A two-fold increase in the ratio between lipid peroxidation and antioxidant 
capacity was reported in the antepartum period in women with preeclampsia (Davidge et 
al., 1992). Significantly lower levels of vitamin C, E, and total thiol were seen in women with 
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preeclampsia (Kharb et al., 2000). In patients with preeclampsia, antioxidants scavenge the 
increased free radicals, resulting in lowered antioxidant levels. Water-soluble antioxidants 
may function as a first line of antioxidants to scavenge excess of reactive oxygen species in 
plasma, whereas lipid soluble antioxidants such as tocopherol and carotene scavenge 
reactive oxygen species affecting the membrane lipids (Mikhail et al., 1994).  
The activities of placental superoxide dismutase and glucose-6-phosphate dehydrogenase 
are decreased in preeclampsia compared to normal pregnancy (Poranen et al., 1996). 
Moreover, the activity and mRNA expression of Cu,Zn-SOD, glutathione peroxidase, and 
tissue levels of vitamin E are significantly lower in placental tissues from preeclampsia than 
from normal pregnancy (Wnag & Walsh, 1996). Glutathione and its related enzymes are 
antioxidants that help detoxify the increased generation of free radicals. Significantly 
reduced whole blood glutathione levels have been reported in women with preeclampsia 
and HELPP syndrome (Madazil et al., 2002; Knapen et al., 1998). 
4.1.3 Leukocyte activation 
The other main caracteristics of preeclampsia is the exacerbated inflamatory state (Bretelle et 
al., 2004; Holthe et al., 2005; Redman et al., 1999). Activated leukocytes, both monocytes and 
granulocytes, generate excess reactive oxygen specieses resulting in oxidative stress (Holthe 
et al., 2004). Compared with normotensive pregnant women, women with preeclampsia 
have higher levels of calprotectin, a protein involved in various physiological inflammatory 
processes, which is indicative of leukocyte activation (Holthe et al., 2005). The expression of 
surface adhesion molecules on cord blood neutrophils was significantly higher in infants 
born to women with preeclampsia than in infants born to the control subjects. Increased 
TNF secretion by leukocytes was detected in blood from patients with preeclampsia, 
providing further evidence of leukocyte activation (Beckman et al., 2004). TNF-ǂ can 
activate the endothelial cells and upregulate the gene expression of numerous molecules 
such as platelet-derived growth factor, cell adhesion molecules, endothelin-1 and PAI-1. 
These molecules have been reported to have detrimental effects on the vasculature and also 
characterize preeclamptic pregnancy (Hajjar et al., 1987; van Hinsbrgh et al., 1988). 
Furthermore, chronic infusion of TNF-ǂ into rats during late pregnancy results in a 
significant increase in renal vascular resistance and arterial pressure (Alexander et al., 2002; 
Giardina et al., 2002). 
4.1.4 Endothelial cell dysfunction  
Endothelial dysfunction is also one of the main pathogenic features of preeclampsia. The 
markers of endothelial dysfunction such as tissue plasminogen activator, von Willebrand 
factor, sE-selectin, and fibronectin are elevated in patients with preeclampsia (Aydin et al., 
2004; Stubbs et al., 1984; Halligan et al., 1994). Although the exact mechanisms of vascular 
endothelial damage in preeclampsia are unclear, increased lipid peroxidation may lead to 
endothelial cell dysfunction (Davidge et al., 1996). Tumor necrosis factor (TNF), tissue factor 
(TF) of placental origin, endothelial nitric oxide synthase (NOS), and excessive activity of the 
enzyme polymerase may contribute to endothelial dysfunction. Compared with 
normotensive pregnant women, women with preeclampsia have reduced expression of 
constitutive nitrite oxidative stress -mRNA, and this lead to reduced production of NO. 
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NOS inhibition consequence is the increased endothelial permeability and an abnormal 
response of the endothelial cells to the stress (Wang et al., 2004). In preeclampsia greater 
nitrotyrosine immunostaining were found in placental villous vascular endothelium and its 
surrounding smooth muscle cells, and also in villous stromal cells compared to normal 
pregnant controls (Myatt et al., 2006). Moreover particularly intense immunoreactivity of 
nitrotyrosine was measured within the invasive cytotrophoblasts in placental biopsies and 
vascular endothelium in the floating villi obtained from women with preeclampsia (Many et 
al., 2000). 
4.1.5 Vascular developement 
Aberrant placental vasculature development and abnormal placental blood flow are 
characterized by increased impedance in Doppler velocimetry (Farag et al., 2004). These 
abnormalities significantly correlated with expression of tissue factor in the placenta of 
women with severe preeclampsia (Di Paolo et al., 2003). The expression of tissue factor was 
found to be markedly increased in the endothelial cells within the basal deciduus. Doppler 
impedance modifications were significantly correlated to the endothelial cell activation. 
Tumor necrosis factor, a circulating cytokine, has also been implicated as causing 
endothelial dysfunction in preeclampsia (Hung et al., 2004). Significantly higher tissue levels 
of tumor necrosis factor were demonstrated in the placenta from women with preeclampsia 
(Wang et al., 1996). Higher levels of tumor necrosis factor lead to increased generation of E-
selectin, a marker of endothelial activation of umbilical endothelial cells. 
4.2 Oxidative stress in gestational diabetes (GDM) 
Gestational diabetes is defined as a carbohydrate intolerance of variable severity, which 
begins, or is identified during the pregnancy (Lopez et al. 2011). The prevalence of 
gestational diabetes mellitus is around 5% of all pregnancies (Ben Haroush et al., 2004). The 
presence of this disease increases the risk of macrosomia, perinatal morbido-mortality 
(Ostlund et al., 2003) and subsequent developement of type 2 diabetes mellitus. The 
pathophysiology of gestational diabetes remain unclear. Pregnant women with gestational 
diabetes have a reduction in insulin sensitivity (Catalano et al., 1999), hypergicemia, and 
hyperlipidemia. Oxidative stress implication in developement of the disease is a result of 
imbalance between the increase in the formation of reactive oxidative substances (Brownlee, 
2001; Maddux et al., 2001) and the insufficience of antioxidative defence mechanisms (Chen 
et al., 2003).  
4.2.1 Induction of oxidative stress in gestational diaetes pathways 
Hyperglycemia induces oxidative stress and cell and tissue damage through several 
metabolic mechanisms.  
These include the formation of advanced glycation endproducts (AGE), activation of protein 
kinase C (PKC), the hexosamine pathway, and increased reactive oxygen specieses 
production in the mitochondria. An important source of free radicals in diabetes is the 
interaction of glucose with proteins. Maillard reaction that form by nonenzymatic glycation 
through covalent attachment of highly reactive aldehyde or ketone groups of reducing  
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Fig. 3. Mechanisms by which hyperglycemia induces cellular dysfunction and damage.  
carbohydtrates and the free amino groups on proteins, lipids, and nucleic acids. Elevated 
concentration of glucose leads to enhanced formation glycolytic products which together 
with the tricarboxylic acid (TCA) cycle intermediates provide glycation of intracellular 
proteins. The interaction of aldehyde groups of glucose with free amino groups on proteins 
generates a Schiff's base.  Extracellular AGE can bind to the AGE receptor (RAGE), a multi-
ligand member of the immunoglobulin superfamily. Engagement of RAGE by AGE results 
in activation of intracellular signaling molecules resulting in oxidative stress and 
inflammation. Since oxidative stress induction and inflammation are closely associated with 
gestational diabetes (Coughlan et al., 2001; Lappas et al., 2004), it is plausible that the AGE-
RAGE system could play a role in the pathogenesis of this metabolic disease. During 
pregnancy, the AGE-RAGE axis may be involved in oxidative and inflammatory responses. 
Specifically, AGE-BSA stimulated the release of the pro-inflammatory cytokines IL-1ǃ, IL-6, 
IL-8, and tumor necrosis factor (TNF)-ǂ and prostaglandins PGE2 and PGF2ǂ. NF-κB and 
MAPK activate expression of several pro-inflammatory genes, including pro-inflammatory 
cytokines, the adhesion molecules vascular cell adhesion molecule (VCAM)-1, and 
intercellular cell adhesion molecule (ICAM)-1, and RAGE causing cellular inflammation. 
This is consistent with gestational diabetes being closely associated with low-grade 
inflammation (Kirwan et al., 2002) and atherosclerosis (Anastasiou et al., 1998; Hannemann 
et al., 2002). Additionally, the activation of cytokines by AGE in human placenta may also be 
involved in insulin resistance associated with gestational diabetes (Colomiere et al., 2009).  
Hyperglycemia also activats  hexosamine biosynthetic pathway (Rajapakse et al., 2009). This 
pathway of glucose metabolism uses fructose-6-phosphate derived from glycolysis to 
metabolize glucosamine-6-phosphate by glucosamine-6-phosphate amidotransferase. 
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Glucosamine-6-phosphate is a competitive inhibitor of glucose-6-phosphate dehydrogenase 
(G6PDH). Glucosamine-6 phosphate produced in the hexosamine pathway, leads to 
decreased NAPDH concentrations, diminished cellular GSH levels, and elevated oxidative 
stress. The activity of G6PDH also rapidly increases in response to intracellular reactive 
oxygen specieses production (Jian et al., 2003).  
NADPH oxidase is a membrane enzyme complex accounting for ROS generation by electron 
transport chain and the enzyme is especially important in redox signaling. Under diabetic 
conditions it can be stimulated by AGE, insulin, and angiotensin II. Hypoxia possibly 
induces all these stimuli, which can activate NADPH oxidase. Once activated in response to 
high glucose levels, NADPH oxidase catalyzes the transfer of electrons from NADPH to 
molecular oxygen to produce O2,- convetred to H2O2. High glucose levels lead to generation 
of reactive oxygen specieses by stimulation of NADPH oxidase (Gao et al., 2009; Gupte et 
al., 2010). 
Under physiological conditions reactive oxygen specieses are eliminated by cellular defense 
mechanisms, including diverse enzymes and vitamins. Imbalance of reactive oxygen 
specieses production and antioxidant systems of a cell can lead to an upregulation of 
expression of antioxidant enzyme encoding genes. Hyperglycemia causes excessive reactive 
oxygen specieses formation, thus activating the Nrf2/ARE pathway (Xue et al., 2008). 
NADPH oxidase was shown to be higher expressed and activated in endothelial cells of 
pregnant women with GDM (Sankaralingam et al., 2009).  Protein kinase C (PKC) promotes 
the activation of mitochondrial NADPH oxidase, thereby leading to oxidative stress events. 
Once stimulated, NADPH oxidase reduces glutathione levels and impairs the cellular 
antioxidant defense systems (King et al., 2004). 
4.2.2 Oxidant species 
Maternal MDA levels in serum and plasma are increased in gestational diabete mellitus 
women compared to normal glucose tolerant (NGT) pregnant women (Chaudhari et al., 2003; 
Surapanieni et al., 2008). Higher levels of lipid peroxidation are evident in patients with poor 
glycemic control. Proteins undergo oxidative damage, they become increasingly susceptible to 
proteolytic degradation. Erythrocytes contain proteolytic enzymes that can degrade 
oxidatively damaged proteins such as hemoglobin, thus preventing the accumulation of 
nonfunctional proteins and protein fragments. GDM is associated with higher levels of 
maternal erythrocyte proteolytic activity than NGT controls (Kamath et al., 1998). 
4.2.3 Antioxidants  
The level of total superoxide dismutase in placental tissues of gestational diabetes mellitus 
(both diet- and insulin-controlled) patients is lower (Kinalski et al., 2001) or did not 
significantly change (Biri et al., 2006; Lappas et al., 2010). Relative ratio of Cu,Zn-SOD to 8-
isoprostane or protein carbonyl was lower in gestational diabetes mellitus placentas, 
suggesting that the increase in superoxide deismutase is not sufficient to compensate for the 
developed oxidative stress (Coughlan et al., 2004). 
Oxidative stress plays a significant role in both NO overproduction and loss of NO 
bioavailability (Gloire et al., 2006; Xia et al., 2007). Oxidative stress leads to NOS-dependent 
www.intechopen.com
 
The Role of Oxidative Stress in Female Reproduction and Pregnancy 
 
327 
increases in NO production in different tissues. Reduction in NO-induced stress is related to 
diabetes-induced endothelial dysfunction, NOS activation can also be induced by diabetes. 
NO induces the expression of antioxidant enzymes Mn- and Cu,Zn-SODs, and heme 
oxygenase-1 and increases intracellular glutathione concentration (Moellering et al., 1999). 
Although NO stimulates O2−-induced lipoperoxidation in membranes, it can also mediate 
protective reactions to inhibit O2− and ONOO− induced lipoperoxidation (Rubbo et al., 
1994). NO production has been found increased in the placenta, placental veins and arteries, 
and in umbilical vein endothelial cells from estational diabetes mellitus patients (Figueroa et 
al., 2000; vonMadach et al., 2003). NOS expression is also altered, as NOS has been found 
overexpressed in the placenta and eNoxidative stress increased in umbilical vein endothelial 
cells from estational diabetes mellitus patients (SanMartin et al., 2006). In estational diabetes 
mellitus, increases in reactive oxygen specieses and NO production, evident in the placenta 
and umbilical vessels, lead to peroxynitrite formation. In platelets from estational diabetes 
mellitus patients, elevated NOS activity and peroxynitrite production have been reported, 
possibly associated with platelet dysfunction and membrane damage due to increased lipid 
peroxidation (Mazzanti  et al. , 2004). Strong protein nitration is found in term placentas 
from diabetic rats. Collectively, these data provide evidence of reactive nitrogen species 
(RNS)-induced damage in estational diabetes mellitus in the placenta and the vasculature of 
the mother, the placenta, and the umbilical cord, produced as a resulting consequence of 
exacerbated NO and ROS production. 
4.2.4 Role of oxidative stress in gestational diabetes-induced teratogenesis 
Diabetes in pregnancy is associated with suboptimal decidualization (Garris et al., 1988). 
NO plays a key role in decidualization and embryo implantation (Norwitz et al., 2001). It 
increases vascular permeability, vasodilation, and blood flow in the uterus, and is a 
component of the decidual cell reaction (Valdes et al., 2009). Diabetes during pregnancy is 
associated with embryonic dysmorphogenesis. Due to its capacity to regulate cell survival, 
apoptosis, differentiation, oxidative and nitrosative stresses play a significant role in embryo 
organogenesis. Low and high levels of NO can lead to embryonic maldevelopment, possibly 
due to an improper regulation of apoptotic events. During embryo and fetal development, 
NO has been found to be relevant in regulating differentiation of lung branching 
morphogenesis, cephalic morphogenesis, heart development, and nephrogenesis (Bloch et 
al., 1999; Tain et al., 2010). 
Transcription factors, as paired box (PAX)-3 and peroxisome proliferator-activated receptor 
(PPAR) δ, has been found to be involved in the induction of both neural tube and heart 
malformations, the most common malformations in gestational diabetes pregnants (Higa et 
al., 2007; Loeken et al., 2006). Different antioxidants such as ǂ-tocopherol and gluthatione 
ethyl ester increase expression of PAX-3 and prevent apoptosis and the induction of 
hyperglycemia-induced neural tube and heart defects (Chang et al., 2003; Morgan et al. 
2008). The higher 8-isoprostane levels observed in the offspring of diabetic animals (Wentzel 
& Erikkson, 2002; Wentzel et al., 1999) have its own teratogenic potency. Diabetic 
embryopathy is also associated with inhibition of GAPDH activity resulting from an excess 
of reactive oxygen speciesesin the embryo (Wentzel et al., 2002). Oxidative glucose 
metabolism is low and about 80% of the glucose used by the placenta. The effect of oxidative 
stress on placental glucose metabolism is not known. However, in nongestational tissues, 
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there is certainly evidence demonstrating oxidative stress regulates GLUT-1 and/or GLUT-3 
dependent glucose uptake and transport. On the other hand estational diabetes mellitus 
placenta is less sensitive to oxidative stress due to the heightened level of antioxidants. 
Under normal conditions, physiological levels of reactive oxygen speciesespromote and 
stimulate adequate insulin signaling. The insulin signaling pathway leads to low levels of 
reactive oxygen species production itself and ROS act as second messengers of which 
disposal impairs insulin signaling. Insulin-induced reactive oxygen specieses production is 
accounted for by activation of the NADPH oxidase NOX4 through PI3K. The reactive 
oxygen speciesespathway subsequently activates kinases or induces gene expression by 
redox-sensitive transcription (Omroy, 2007). 
4.3 Intrauterine Growth Restriction (IUGR) 
Fetal growth depends on the interactions of genetic and epigenetic determinants functioning 
against an environment of maternal, fetal, and placental influences (Gardosi et al., 1992). 
Intrauterine growth restriction (IUGR) manifests as a variable syndrome of suboptimal 
growth and body disproportions rather than a well-defined etiologic entity. Causes for 
IUGR are diverse and include aneuploidies, non-aneuploid syndromes, infections, metabolic 
factors and placental disorders.  IUGR places the fetus and neonate at risk of death or 
disability in the perinatal period (Baschat et al. 2000; Bernstein et al. 2000) and predisposes 
the child to a lifelong increased risk for hypertension, cardiovascular disorders and renal 
disease, among others (Murphy et al., 2006). A common definition is an estimated fetal 
weight less than the 10th percent for gestational age. Diminished fetal arterial and venous 
Doppler flows in key vascular beds predict worsening fetal acid base status (Rizzo et al., 
2001; Baschat et al. 2004) and such findings frequently lead to delivery of a markedly 
premature baby to avoid in utero demise.  
A diverse number of stimuli and mediators contribute to the observed injury to the 
chorioallantoic villi but oxidative stress is high on the list as an injurious agent (Hung et al., 
2002). The production of reactive oxygen species during oxidative stress is linked with tissue 
injury in many diseases (Ryter et al., 2007). Paper shows that the placentas of pregnancies 
with IUGR exhibit overt signs of oxidative stress, with reduced protein translation and 
particular reductions in key signalling proteins pathways (Yung et al., 2008). Moreover, the 
syncytiotrophoblast shows signs of endoplasmatic reticulum (ER) stress by activating the 
unfolded protein response, which leads to an ER signal for enhanced apoptosis. The 
identified dysregulation of protein translation, signalling pathways and trophoblast 
turnover in placentas of pregnancies with IUGR (Burton et al., 2009). Hypoxia, 
ischaemia/reperfusion, or both may contribute to placental injury through mechanisms 
other than reactive oxygen species generation, as variable blood flow to organs also 
activates the complement cascade (Levy et al., 2000; Hung et al., 2002; Heazell et al,. 2008). 
Activation of the complement cascade injure the feto-placental unit (Girardi et al,. 2003).  
Clarifying the role of complement activation in pregnancies complicated by IUGR, and in 
placental dysfunction generally, may lead to new approaches to treatment for IUGR, as 
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5. Role of antioxidant supplementation in pregnancy 
Clinical and research centers are investigating the usefulness of antioxidant 
supplementation and their role in prevention of pathological pregnancies. Antioxidant 
supplementation, for example vitamin C and vitamin E, has been shown to have beneficial 
effects in preventing luteal phase deficiency and resultant increased pregnancy rate (Hemi 
et al., 2003; Crha et al., 2003). Meta-analysis investigating the intervention of vitamin-C 
supplementation in pregnancy was inconclusive (Rumbold et al, 2005). Another meta-
analysis of women taking any of the vitamin supplements started prior to 20 weeks’ 
gestation revealed no reduction in total fetal losses, or in early and late miscarriage, having 
used the fixed-effects model. Improved pregnancy rates were also reported with 
combination therapy with the antioxidants pentoxifylline and vitamin-E supplementation 
for 6 months in patients with thin endometria who were undergoing in vitro fertilization 
with oocyte donation (Ledee-Bataille et al., 2002). Supplementation with vitamin E has also 
been reported to prevent the deleterious effects of ethanol toxicity on cerebral development 
in the animal model (Peng et al., 2005). There are essential differences among the population 
groups and the dosage and duration of supplementation for prevention of preeclampsia. 
Although many advances are being made in the field of antioxidants therapy, the data are 
still debatable and need further controlled evaluations in larger populations (Ashok et al., 
2006). 
6. Conclusions 
The establishment of pregnancy requires a harmonic hormonal, ovarial and fallopian tube 
function, a receptive uterus able to respond to a variety of biochemical and molecular 
signals produced by the developing conceptus, as well as specific interactions between the 
uterine endometrium and the extra-embryonic membranes. Therefore, the fetal, placental 
development and function are prerequisites for an adequate supply of nutrients and 
oxygen to the fetus and successful establishment of pregnancy. Oxidative stress is a 
complex system, affecting in a complex way the female fertility, and pregnancy outcome. 
The inbalance of the oxidative agents and antioxidants has been proposed as the causative 
agents of female sterility, recurrent pregnancy loss and several pregnancy-related 
disorders, most notably preeclampsia, intra-uterine growth restriction (IUGR) and 
gestational diabetes. 
Preeclampsia is characterized by increased oxidative stress due to the imbalance between 
lipid peroxidation and antioxidant defense mechanisms, leading to endothelial dysfunction 
and free radical mediated cell injury. Other maternal factors including activated neutrophils 
and imbalance between anticoagulants and procoagulants aggravate the oxidative stress 
and endothelial dysfunction this plays crucial role in developement of the disease. There is 
no doubt that both hypoxia and hypoxia-reperfusion lead to reactive oxygen species 
production, but both may also arise from the same underlying problem of impaired 
conversion of the spiral arteries. The effects of the reduced trophoblast invasion associated 
with complicated pregnancies can easily be superimposed on this basic model. Reduced 
invasion will leave the spiral arteries vasoreactive, and thus more likely to undergo 
spontaneous transient vasoconstriction. They will be more responsive to endogenous and 
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exogenous vasoactive stimuli. Partial obliteration of their lumens by atherotic changes will 
also impair flow. Excessive production of inflammatory cytokines, deportation of apoptotic 
microvillous placental fragments, activation of maternal leukocytes and platelets, or 
depletion of NO production may then cause or contribute to the maternal endothelial 
response. The degree of the oxidative stress will likely reflect the extent of the maternal 
vascular pathology.  
There are a number of pathways that may contribute to oxidative stress observed in the 
gestational diabetes mellitus placenta. In the placenta, reactive oxygen species and 
reactive nitrite spesies are an important source of growth and signaling factors, and are 
susceptible to ROS-mediated apoptosis. The placenta is endowed with many antioxidants, 
some of which are increased in gestational diabetes mellitus. However, there is much data 
to indicate that maternal diabetes during pregnancy may induce oxidative stress in the 
newborn that may entail biochemical disturbances of the fetus (Hung et al., 2006). Given 
that The placenta provides the interface of the maternal and fetal circulations, it may play 
a crucial role in protecting the fetus from adverse effects of the maternal diabetic milieu 
(Lappas et al., 2011). 
The investigation of oxidtive stress is inevitabile for better understanding of aerobe 
organism function. Evaluation of environmental factors effect on oxidative stress molecular 
pathways can sereve possible solutions for female reproductive malfunctions. The are 
several fertility and pregnancy related disease, as unexplained infertility, preeclampsia, 
HELLP syndrome where the reactive oxidative species and antioxidant mechanism play key 
role in pathogenesis of the disease. The antioxidant supplementation, avoidance of different 
enviromental factors, as polluted comestibles may lead to decrease of infertility rate and 
incidence of pregnancy related disorders. 
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